Virtu Financial LLC - PROTEOSTASIS THERAPEUTICS IN ownership

PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 50 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of PROTEOSTASIS THERAPEUTICS IN
ValueSharesWeighting
Q2 2020$48,000
+37.1%
34,930
+124.7%
0.01%
+100.0%
Q4 2019$35,000
+34.6%
15,543
-50.3%
0.00%
+50.0%
Q3 2019$26,000
-69.4%
31,258
-64.0%
0.00%
-60.0%
Q2 2019$85,000
+240.0%
86,859
+335.8%
0.01%
+400.0%
Q1 2019$25,00019,9320.00%
Other shareholders
PROTEOSTASIS THERAPEUTICS IN shareholders Q3 2019
NameSharesValueWeighting ↓
VHCP Management III, LLC 848,610$2,749,0002.00%
GREAT POINT PARTNERS LLC 3,045,423$9,867,0001.25%
NEA Management Company, LLC 5,556,778$18,004,0000.71%
VHCP Management II, LLC 501,390$1,625,0000.70%
SECTORAL ASSET MANAGEMENT INC 1,581,728$5,125,0000.70%
HARBOURVEST PARTNERS LLC 440,627$1,428,0000.68%
EAM Investors, LLC 596,871$1,934,0000.52%
EAM Global Investors LLC 252,778$819,0000.45%
Avoro Capital Advisors LLC 1,300,000$4,212,0000.25%
Ghost Tree Capital, LLC 190,000$616,0000.22%
View complete list of PROTEOSTASIS THERAPEUTICS IN shareholders